[DMAC] YoY Quarter Result on 31-Mar-2019 [#Q1]

Stock
[DMAC] DiaMedica Therapeutics Inc.
Announcement Date
13-May-2019
Financial Year
2019
Quarter
31-Mar-2019 [#Q1]
Profit Trend
QoQ- -206.21%
YoY- -458.76%
Quarter Report
DMAC's Result
DMAC's Financial Summary
View:
Show?
Quarter Result
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -3,501 -3,615 -2,416 -3,243 -580 -1,301 -348 46.90%
Tax 7 7 9 9 1 8 3 15.15%
NP -3,508 -3,622 -2,425 -3,252 -582 -1,309 -351 46.74%
Tax Rate - - - - - - - -
Total Cost 3,508 3,622 2,425 3,252 582 1,309 351 46.74%
Ratio Analysis
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
31/03/22 31/03/21 31/03/20 31/03/19 31/03/18 31/03/17 31/03/16 CAGR
EPS -0.13 -0.19 -0.19 -0.27 -0.09 -0.24 -0.08 8.42%
EPS Diluted -0.13 -0.19 -0.19 -0.27 -0.09 -0.24 -0.08 8.42%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.